Journal of the American Chemical Society, volume 139, issue 34, pages 11630-11641

Recent Advances in Asymmetric Hydrogenation of Tetrasubstituted Olefins

Stefan Kraft 1
Kristen Ryan 1
1
 
Drug Discovery Services, Medicinal Chemistry, Albany Molecular Research Inc., 26 Corporate Circle, Albany, New York 12201-5098, United States
Publication typeJournal Article
Publication date2017-08-21
scimago Q1
SJR5.489
CiteScore24.4
Impact factor14.4
ISSN00027863, 15205126
PubMed ID:  28800391
General Chemistry
Catalysis
Biochemistry
Colloid and Surface Chemistry
Abstract
The asymmetric hydrogenation of tetrasubstituted olefins provides direct access to very useful biological molecules and intermediates. The development of the technology has been slow, due in part to the synthetic challenges involved in developing chiral catalysts for a successful asymmetric induction. We briefly recount the breakthroughs in functionalized and unfunctionalized tetrasubstituted olefins, from the reports of Zhou and Buchwald for functionalized and unfunctionalized substrates, respectively, to the advent of chiral phosphoramidite ligands. The main emphasis of this Perspective lies in bringing into focus the complexity and challenges of inducing an asymmetric reduction for these substrates, which includes a brief discussion of the mechanism, the latest developed chiral catalysts, and the enormous scientific opportunities that still exist in developing "go to" catalyst systems for the various substrate types.
Found 

Top-30

Journals

2
4
6
8
10
12
14
16
18
2
4
6
8
10
12
14
16
18

Publishers

10
20
30
40
50
60
10
20
30
40
50
60
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Share
Cite this
GOST | RIS | BibTex | MLA
Found error?